Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community

Iron deficiency and risk of early readmission following a hospitalization for acute heart failure

(2016) Julio Núñez et al.   EUROPEAN JOURNAL OF HEART FAILURE

High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND

(2016) Niels Grote Beverborg et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Hemoglobin levels and new-onset heart failure in the community

(2015) IJsbrand T. Klip et al.   AMERICAN HEART JOURNAL

The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences

(2014) IJsbrand T. Klip et al.   EUROPEAN JOURNAL OF HEART FAILURE

mRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overload

(2014) Casey J. Brewer et al.   EXPERIMENTAL HEMATOLOGY

Serum Hepcidin Is Associated With Presence of Plaque in Postmenopausal Women of a General Population

(2013) Tessel E. Galesloot et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Iron Deficiency and Cardiovascular Disease: An Updated Review of the Evidence

(2013) Emanuela Lapice et al.   Current Atherosclerosis Reports

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

(2013) F. P. Brouwers et al.   EUROPEAN HEART JOURNAL

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

(2013) Walter J. Paulus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Iron deficiency is associated with increased risk for cardiovascular disease and all-cause mortality in the elderly living in long-term care facilities

(2013) Hua-Shui Hsu et al.   NUTRITION

Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform

(2013) Coby M. M. Laarakkers et al.   PLoS One

Iron: Protector or Risk Factor for Cardiovascular Disease? Still Controversial

(2013) Carlos Muñoz-Bravo et al.   Nutrients

Testing the Iron Hypothesis in a Mouse Model of Atherosclerosis

(2013) Léon Kautz et al.   Cell Reports

Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients

(2012) Neelke C. van der Weerd et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis

(2011) Omar Saeed et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation

(2011) Paul C. Adams et al.   JOURNAL OF HEPATOLOGY

Multimarker Approach for the Prediction of Heart Failure Incidence in the Community

(2010) Raghava S. Velagaleti et al.   CIRCULATION

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

(2010) J. J. C. Kroot et al.   CLINICAL CHEMISTRY

Iron Overload Cardiomyopathy

(2010) Pradeep Gujja et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The metabolic syndrome predicts incident congestive heart failure: A 20-year follow-up study of elderly finns

(2009) Jianjun Wang et al.   ATHEROSCLEROSIS

N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population

(2009) G. C.M. Linssen et al.   EUROPEAN HEART JOURNAL